A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06574568 · RECRUITING
Trial details
- NCT number
- NCT06574568
- Sponsor
- Excyte Biopharma Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-14
- Primary completion
- 2026-12-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.